CHEK2 and oligodendroglioma: To our knowledge, this is the first report that we identified a pathogenic variant CHEK2 p.R137* in an oligodendroglioma patient, which suggests that brain tumor patients with a family history of cancer or other risk factors need to pay more attention to the potential genetic predisposition variant for moderate/low penetrance genes.